Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer.

Francis, D L; Visvikis, D; Costa, D C; Arulampalam, T H A; Townsend, C; Luthra, S K; Taylor, I; Ell, P J

Francis, D L; Visvikis, D; Costa, D C; Arulampalam, T H A; Townsend, C; Luthra, S K; Taylor, I; Ell, P J.

Affiliation

Francis DL; Institute of Nuclear Medicine, Royal Free and University College Medical School, Middlesex Hospital, Mortimer Street, W1T 3AA, London, UK. daren.francis@ucl.ac.uk

Eur J Nucl Med Mol Imaging ; 30(7): 988-94, 2003 Jul.

Article in En | MEDLINE | ID: mdl-12739071

Subject(s)

Colorectal Neoplasms/diagnostic imaging; Dideoxynucleosides; Fluorodeoxyglucose F18; Tomography, Emission-Computed/methods; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Whole-Body Counting

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Dideoxynucleosides / Tomography, Emission-Computed / Fluorodeoxyglucose F18 Type of study: Diagnostic_studies / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2003 Document type: Article Affiliation country: United kingdom Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links